IJCP Group started its journey in June 1990 with its flagship medical journal, the Indian Journal of Clinical Practice, with a brilliant editorial team comprising of doctors and research analysts. Very soon, IJCP grew from this one journal to a Group of Publications. Today, IJCP’s network has traversed borders to win appreciation by the doctors from the different parts of the world. With a wide range of publications, Events & PR, audio & visual, and host of other information packed products, IJCP Group is the preferred partner of not only the Medical fraternity but also the Pharmaceutical companies. But the journey of IJCP does not end here…. We believe this is the beginning of our journey….. Contact us Head Office Dr Veena Aggarwal Mr Nilesh Aggarwal IJCP Publications Pvt. Ltd. Group Executive Editor & DirectorE-219, Greater Kailash Part - I Joint Managing Director 09818421222 New Delhi - 110048 09811036687
Our Management Dr KK Aggarwal Padma Shri & Dr B C Roy Awardee CMD, Publisher and Group Editor-in-Chief President, Heart Care Foundation of India firstname.lastname@example.orgDr KK Aggarwal is a Senior Consultant Physician and Cardiologist and Dean of theBoard of Medical Education Moolchand Medcity, New Delhi. He is the Founder,Trustee and President of Heart Care Foundation of India.Dr. KK Aggarwal has received many prestigious awards, including the Padma Shriand Dr. B C Roy National Award from the 12th President of India, Smt. PratibhaDevisingh Patil, for his unique contributions in the health sector. He is also knownas a writer, columnist and expert for newspapers and TV shows. Dr. Mrs. Veena Aggarwal Group Executive Editor & Joint Managing Director Director, Heart Care foundation of India email@example.comDr Veena Aggarwal, besides being a Consultant in Holistic and Antenatal Care, is aClinical Obstetrician and Gynecologist by profession.Under her dynamic leadership, foresight and quest for perfection, the IJCPGroup has crossed many a milestone and is today a leading healthcarecommunications group.
Journal Indexed with IndMED www.ijcpgroup.com ISSN 0971-0876 Single Copy Rs. 250/- Indian Journal of CLINICAL IJCP PRACTICE Volume 21, Number 7 R ev w Jo ie u al rn 361-420 Pages December 2010 er Pe Esophageal Ulceration Following Typhoid Fever Dr KK Aggarwal Group Editor-in-Chief
Indian Journal of Clinical Practice The flagship journal of IJCP Group of From the Desk oF Group eDitor-in-ChieF From the Desk oF Group eDitor-in-ChieF Publications was launched in June 1990ACS Updates Prostate Cancer Screening Guideline as a monthly medical journal to provide an insight into the proper diagnosis and treatment of diseases and conditions commonly encountered by an Indian physician. IJCP is unquestionably India’s Dr KK Aggarwal Padma Shri and Dr BC Roy National Awardee leading medical journal. Sr Physician and Cardiologist, Moolchand Medcity President, Heart Care Foundation of India Group Editor-in-Chief, IJCP Group Editor-in-chief, eMedinewS Chairman Ethical Committee, Delhi Medical Council Director, IMA AKN Sinha Institute (08-09) Hony. Finance Secretary, IMA (07-08) Chairman, IMA AMS (06-07) President, Delhi Medical Association (05-06) firstname.lastname@example.org Specifications http://twitter.com/DrKKAggarwal Krishan Kumar Aggarwal (Facebook)T he American Cancer Society (ACS) has updated its prostate cancer screening guideline. Men should only be screened after they receive information about the uncertainties, risks, and potential benefits associated with prostate cancer screening. Size: A4 Prostate-specific antigen (PSA) testing is now recommended with or without the digital rectal exam (DRE). There is little evidence that the DRE adds significant benefit to the PSA test, except, perhaps, when the PSA is in the borderline range. Pages: 56+4 PSA value of 4.0 ng/ml be used as a reasonable threshold to trigger further evaluation. There is a new recommendation for men with PSA values between 2.5 and 4.0 ng/ml. Twenty-five percent of men with PSA levels between 2.5 and 4.0 ng/ml harbor prostate cancer and physicians should consider an Printing: 4+1 Color individualized risk assessment for these men. Paper: 210/90 GSM Indian Art Paper An individual assessment should take into account non-PSA risk factors, such as race, family history, results of previous biopsies and DRE results. ACS also now recommends that the PSA testing interval be reduced to every other year for men whose PSA level is under 2.5 ng/ml. Such a reduction in testing frequency will lead to significantly reduced false positives, unnecessary biopsies and overdiagnosis, with only a negligible increase in missed cancers. Source: CA Cancer J Clin Published online March 3, 2010. Frequency: Quarterly n n n Readership: 50,000 Cover Price: ` 300/-Indian Journal of Clinical Practice, Vol. 21, No. 9, February 2011 485 Annual Subscription: ` 3500/-
IJCP’s Medinews Launched in June 1992, Medinews isControlled-Release Tramadol in Chronic Pain India’s first and most comprehensiveC hronic pain is different from acute pain. It can be multifactorial; often it may not be possible to find out if Advantages of CR Tramadol medical newspaper.it is nociceptive, neuropathic, idiopathic or all of the above, • Extended duration of action for reduced dosing Medinews features healthcare news aswhich in turn affects the duration and treatment.1 More frequencythan 40-50% of patients in routine practice settings fail to • More constant plasma concentrations for improvedachieve adequate relief making chronic pain a particular efficacy and tolerabilitychallenging problem to treat. Besides its impact on quality-of-life (QOL), chronic pain incurs great healthcare costs.2Available analgesics include nonopioids such as • Improved compliance and therapeutic outcomes The bioavailability of the CR tramadol formulation is an unbiased and well reasoned analysis and covers medical events, nationallyacetaminophen, nonsteroidal anti inflammatory drugs(NSAIDs), cyclo oxygenase-2 (COX-2) inhibitors, weak comparable with IR (immediate release) formulations,opioids such as codeine and tramadol and conventional with a half-life 3-4 times longer (16 hours vs 4-6 hours)opioids such as oxycodone and morphine.3 NSAIDs and and an extent of absorption similar to IR tramadol given and internationally in a well-illustratedacetaminophen are the cornerstone of treating most pain thrice-daily.11conditions. But, their analgesic efficacy varies widely among Tramadol has been widely studied in the treatment of chronicindividual patients. Gastrointestinal toxicity is present in pain, such as osteoarthritis, low back pain, cancer pain and50% of NSAIDs users and 5.4% develop a more seriousevent requiring hospitalization due to their frequent use.4NSAIDs may have a possible deleterious effect on articular neuropathic pain.6 CR tramadol is shown to be more effective in terms of analgesia compared to standard formulation of tramadol both six and 12 hours after administration. It also format. Medinews has enjoyed the OFFICIAL PRESS status at premiumcartilage metabolism.5 They may affect fluid and electrolyte has fewer adverse effects than the standard formulation.12balance, causing fluid retention, edema and hypertension.6 A double-blind crossover comparative study has reportedMost patients above 65 years have multiple co-morbid disease significant improvement in pain intensity with CR tramadolconditions such as heart disease, diabetes, hypertension, as compared with IR tramadol and higher patient-ratedAlzheimer’s and renal disease that significantly complicatetreatment of pain.3 treatment effectiveness.13 CR tramadol therefore provides the advantage of around-the-clock analgesic control with reduced dosing frequency which is essential to obtain patient National conferences like APICON, CSI,Tramadol, an Atypical Opioid AnalgesicTramadol is a synthetic, centrally acting analgesic that has compliance in conditions of chronic pain. CR Tramadol in Osteoarthritis AICOG, PEDICON, IMA-CON, IADVL andbeen used to treat pain effectively in a variety of indications.7It belongs to the second step of the WHO analgesic ladder.Tramadol has an atypical pharmacological profile withboth opioid and monoaminergic mechanisms. It exerts its A chronic degenerative disorder of multifactorial etiology, osteoarthritis (OA) is the second most common rheumatological problem and is the most frequent joint NAPCON for the last 5 years.analgesic effects by complementary mechanisms of action: disease with prevalence of 22-39% in India. Pain along withIt binds weakly to µ-receptors and inhibits ascendent pain functional limitation and stiffness are the major symptomstransmission pathways in the spinal cord. At the same time, making OA the most common cause of locomotor disabilityit stimulates descendent inhibitory pathways by increasing in the elderly.4 Effective pain control is one of the goalsrelease and decreasing re-uptake of noradrenaline and Specifications of treatment,5 which depends on the analgesic efficacy ofserotonin.8 The (+) enantiomer is more potent than the treatment and compliance with the dosing regimen.7the (–) enantiomer in inhibiting serotonin reuptake. On theother hand, the (–) enantiomer is more potent in inhibiting CR tramadol is an efficacious and well-tolerated medicationnorepinephrine reuptake and increasing presynaptic release. for the treatment of OA pain.11 The American Pain SocietyThis differential interaction between the two enantiomers is recommends tramadol for the management of OA painsynergistic.6 The dual mechanism of action gives tramadol when NSAIDs alone produce inadequate pain relief.11 The Size: A4 Size recommendations of the American Heart Association include an efficacy that is equivalent to codeine, despite a 10-foldlower affinity to µ-receptors.8 Tramadol does not have tramadol, not NSAIDs or COX-2-specific inhibitors, asthe typical opioid adverse effects at the respiratory and first-line therapy for musculoskeletal symptoms in patientscardiovascular level and on intestinal motility at therapeutic with cardiovascular disease or risk factors.6 Pages: 12+4/20+4doses.9 In addition, it avoids the ulcerogenic, renal/cardiac/hepatic adverse effects of NSAIDs and COX-2 inhibitors.This feature combined with the lower potential for abuse In a 12-week clinical trial of OA of the knee, CR formulation of tramadol provided patients with increased control over the management of their pain, fewer interruptions in sleep or dependence, gives tramadol a significant advantage over and improved compliance.14 Clinical data on tramadol and Paper: 70/130 GSM Indian Art Papernonopioids and also over conventional opioids, particularly paracetamol indicate that both the parent drug (tramadol)in the elderly.3 and its active metabolite achieved adequate concentrations inTramadol has a half-life of about 5.5 hours and the usual oral synovial fluid in comparison to paracetamol.15 The results ofdosage regimen is 50-100 mg every 4-6 hours (maximum a long-term open label study demonstrated that CR tramadol Printing: 4 Colordose: 400 mg/day). To reduce the frequency of administration is effective for the long-term management of OA pain.and to improve patient compliance, a controlled-release Reductions in pain intensity, improvements in sleep(CR) formulation of tramadol has been developed.10 and functionality and most QOL measures reported in Readership: 1,00,000 Frequency: Monthly Cover Price ` 100/-Advertisement Tariff Annual subscription ` 1200/-Position Dimension (H X W/Cm.) Amount (`/Advt.)Front Solus 15 x 10 ` 40,000Back Solus 22 x 34 ` 35000Full Page ` 40,000/-RHS Pages Economy 15 x 10 ` 30,000/-LHS Pages Economy 15 x 10 ` 25,000/-
Journal Peer Review Journal ISSN 0972-70035 Single Copy Rs. 250/- www.ijcpgroup.com Volume 13, Number 8, December 2010, Pages 197-236 Dr KK Aggarwal Dr Praveen Chandra Group Editor-in-Chief Guest Editor
Asian Journal of Clinical Cardiology Asian Journal of Clinical Cardiology (AJCC) From the Desk oF Group eDitor-in-ChieF xxxxxxxxxxx is an ambitious attempt by IJCP GroupNew Test to Predict Cardiac Risk in HealthyPatients to publish a journal of international standards.Highly sensitive assay for cardiac troponin T (cTnT) can predict cardiovascular events in apparently healthypopulations. As part of the Dallas Heart Study, cTnT levels were measured using both standard and highlysensitive assays in more than 3,500 patients ages 30 to 65. The results were published in the Dec. 8 Journal of Dr. Praveen Chandra, Interventional Cardiologist, Medanta Medcity is the Editorthe American Medical Association 2010. The standard assay found detectable cTnT in only 0.7% of the studyparticipants, while the highly sensitive test found it in 25%. Only 7.5% of people in the lowest cTnT grouphad left ventricular hypertrophy compared to 48.1% in the highest cTnT group. Mortality also increased from1.9% in the lowest group to 28.4% in the highest. cTnT was independently associated with all–cause mortality(adjusted hazard ratio, 2.8 in the highest cTnT group). of the journal. Dr Chandra and a network of eminent Indian and internationalAnother study in the same issue tested the highly sensitive cTnT assay’s ability to predict heart failure in more than4,000 community–dwelling elderly patients. The biomarker was detectable in the majority of patients (66.2%)and associated with an increased risk of heart failure and cardiovascular death at higher concentrations (4.8 deathsper 100 in highest group compared to 1.1 in patients with undetectable levels). This study continued cTnTmeasurements over time and found that increases of more than 50% were also associated with cardiovascular cardiologists are toiling tirelessly to makeevents.In both studies, there was significant overlap between cTnT and N–terminal pro–brain–type natriuretic peptide,suggesting that more accurate predictions may be achieved by use of both tests together. AJCC a world class cardiology journal. Specifications Size: A4 Pages: 36+4Dr KK AggarwalPadma Shri and Dr BC Roy National AwardeeSr Physician and Cardiologist, Moolchand MedcityPresident, Heart Care Foundation of India Printing: 4+1 colorGroup Editor-in-Chief, IJCP GroupEditor-in-Chief, eMedinewSChairman Ethical Committee, Delhi Medical CouncilDirector, IMA AKN Sinha Institute (08-09) Paper: 210/90 GSM Indian Art PaperHony. Finance Secretary, IMA (07-08)Chairman, IMA AMS (06-07)President, Delhi Medical Association (05-06)email@example.com Frequency: Monthlyhttp://twitter.com/DrKKAggarwalKrishan Kumar Aggarwal (Facebook) Readership: 10,000Asian Journal of Clinical Cardiology, Vol. 13, No. 9, January 2011 237 Cover Price ` 300/- Annual Subscription ` 3500/-
Journal Editorial Volume : 1 January-March 2011 Indian Journal of Clinical Practice, Vol. 20, No. 6, November 2009
Asian Journal of Obstetrics Gynecology From the desk oF group editor-in-chieF Asian Journal of Obs Gynae Practice was Paracetamol for Fever in Pregnancy launched in December 1996 as the first of the series of specialized journals under the ‘Asian Series’. The journal covers a Dr KK Aggarwal Padma Shri and Dr BC Roy National Awardee Sr Physician and Cardiologist, Moolchand Medcity whole range of topics in the specialty, President, Heart Care Foundation of India Group Editor-in-Chief, IJCP Group Editor-in-Chief, eMedinewS from antenatal care to general gynecology to operative obstetrics including its Chairman Ethical Committee, Delhi Medical Council Director, IMA AKN Sinha Institute (08-09) Hony. Finance Secretary, IMA (07-08) Chairman, IMA AMS (06-07) President, Delhi Medical Association (05-06) firstname.lastname@example.org subspecialities of Urogynecology, Oncology http//twitter.com/DrKKAggarwal Krishan Kumar Aggarwal (Facebook) and Reproductive Endocrinology. E levation of maternal core temperature from a febrile illness or other source (e.g. hot tub) in the first trimester of pregnancy may be associated with an increased risk for neural tube defects or miscarriage. The National Birth Defects Prevention Study, however observed that among women with infection-related fever, use of paracetamol was associated with a statistically significant reduction in neural tube defects, as well as Dr Alka Kriplani, Professor, Dept. of cleft lip/palate and gastroschisis. The data support the safety of paracetamol for relief of fever and pain; however, the reduction in birth defects should be confirmed in other studies before the drug can be recommended to febrile Obstetrics and Gynecology, AIIMS, is the women for this purpose. Evidence Editor of the journal. To investigate whether exposure during the first trimester of pregnancy to single-ingredient acetaminophen increases the risk of major birth defects. Data from the National Birth Defects Prevention Study, a population- based, case-control study, were used. Women who delivered between January 1, 1997, and December 31, 2004 Specifications and participated in the telephone interview were included. Type and timing of acetaminophen use were assigned based on maternal report. Women reporting first-trimester acetaminophen use in a combination product were excluded, resulting in a total of 11,610 children in the case group and 4,500 children in the control group for analysis. The prevalence of first-trimester single-ingredient-acetaminophen use was common: 46.9% (n = 5,440) among women in the case group and 45.8% (n = 2,059) among women in the control group Readership: 25,000 (p = 0.21). Overall, acetaminophen was not associated with an increased risk of any birth defect. Among women reporting a first-trimester infection and fever, use of acetaminophen was associated with a statistically significantly decreased odds ratio (OR) for an encephaly or craniorachischisis (adjusted OR 0.35, 95% confidence interval [CI] 0.08-0.80), encephalocele (adjusted OR 0.17, 95% CI 0.03-0.87), anotia or microtia (adjusted OR 0.25, 95% CI 0.07-0.86), cleft lip with or without cleft palate (adjusted OR 0.44, 95% CI 0.26-0.75) and gastroschisis (adjusted OR 0.41, 95% CI 0.18-0.94). Size: A4 Single-ingredient-acetaminophen use during the first trimester does not appear to increase the risk of major birth defects. It may decrease the risk of selected malformations when used for a febrile illness. Pages: 48+4 Source: Feldkamp ML, Meyer RE, Krikov S, Botto LD. Obstet Gynecol 2010;115(1):109-15. Printing: 4+2 color n n n Asian Journal of Obs and Gynae Practice, Vol. 1, January-March 2011 Paper: 170/90 GSM Indian Art Paper Frequency: Quarterly Cover Price: ` 300/- Annual subscription ` 1200/-
Asian Journal of Diabetology From the Desk oF Group eDitor-in-chieF The Asian Journal of Diabetology is aChanging Practice Guidelines: A1C prestigious quarterly journal. Dr Vijay Vishwanathan, an eminent Diabetologist, Managing Director, MV Hospital for Diabetes and Diabetes Research Center, Chennai is the Editor of the journal. Dr KK Aggarwal Padma Shri and Dr BC Roy Awardee Sr Physician and Cardiologist, Moolchand Medcity The journal focuses on informing Physicians and Diabetologists about President, Heart Care Foundation of India Group Editor-in-Chief, IJCP Group Editor-in-Chief, eMedinewS Member, Delhi Medical Council Director, IMA AKN Sinha Institute (08-09) Hony. Finance Secretary, IMA (07-08) managing various aspects of diabetes Chairman, IMA AMS (06-07) President, Delhi Medical Association (05-06) email@example.com to provide better patient care to India’s continually rising population ofT diabetics. he American Diabetes Association (ADA), the International Diabetes Federation (IDF) and the European Association for the Study of Diabetes (EASD) have joined forces to recommend the use of the hemoglobin A1C assay for the diagnosis of diabetes.A1C values vary less than FPG (fasting plasma glucose) values and the assay for A1C has technical advantagescompared with the glucose assay. A1C gives a picture of the average blood glucose level over the preceding Specifications2-3 months.A1C has numerous advantages over plasma glucose measurement: It is a more stable chemical moiety. The patient does not need to fast. Readership: 5,000 Measuring A1C is more convenient and easier for patients who will no longer be required to undergo a fasting or oral glucose tolerance test (OGTT). It correlated tightly with the risk of developing retinopathy. Size: A4The committee has determined that an A1C value of 6.5% or greater should be used for the diagnosis of diabetes.This cut-point, is where risk of retinopathy really starts to go up. Avoid using estimated average glucose, or EAG, as this is just a way to convert the A1C into glucose levels. Source: American Diabetes Association (ADA) 69th Scientific Sessions. Presented June 5, 2009. Diabetes Care Published online June 5, 2009. Pages: 36+4 Printing: 4+2 color Paper: 170/90 GSM Indian Art PaperAsian Journal of Diabetology, Vol. 12, No. 1, January-March 2010 Frequency: Quarterly Cover Price: ` 300/- Annual Subscription ` 1200/-
Journal Volume 6, Number 3 July-September 2010 Sedation Practices for the Patient in the ICU Should C-reactive Protein Concentration at ICU Discharge be Used as a Prognostic Marker? Clostridium Difﬁcile: Moving Beyond Antimicrobial Therapy ICU Intubation Success Hampered by Non-ideal Conditions: Based on Small Cohort Study... Pain Not Minimized after Minimally Invasive Cardiac Surgery Still Asleep at the (Ventilator) Switch? Timing of Tracheotomy Linked to Length of Stay: Study Finds to Effect on Mortality from Early Procedure more...
Asian Journal of Critical Care From the desk oF Group editor-in-chieF Today, the demands on the intensivistsNonresolving Pneumonia are tremendous, making it necessary for them to be updated with the latest in the field. In view of this, IJCP has another specialty journal, Asian Journal of Critical Care. It discusses original research, review articles, Dr. KK Aggarwal Dr BC Roy Awardee technology in medicine for physicians Sr Physician and Cardiologist Moolchand Medcity President, Heart Care Foundation of India Group Editor-in-Chief, IJCP Group and allied health professionals involved Member, Delhi Medical Council Director, IMA AKN Sinha Institute (08-09) Hony. Finance Secretary, IMA (0�-08) Chairman, IMA AMS (06-0�) in treating the critically ill with the aim President, Delhi Medical Association (05-06) firstname.lastname@example.org to improve patient care.S low or incomplete resolution of pneumonia despite treatment is a common clinical problem, estimated to be responsible for approximately 15% of inpatient pulmonary consultations and 8% of bronchoscopies.1 Normal resolution of pneumonia is not easily defined. Patients typically note subjective improvement within Specifications3-5 days of treatment; more specific clinical criteria for resolution include improvement in fever, cough, crackles,leukocytosis, arterial oxygenation (PaO2) and level of C-reactive protein.2Most studies on the natural history of pneumonia have focused upon the resolution of chest radiographic Size: A4abnormalities, with ‘slow resolution’ often being defined as the persistence of radiographic abnormalities forgreater than one month in a clinically improved host.The diagnostic evaluation of treatment failure in pneumonia should begin with a careful history, physical Pages: 36+4examination, and review of the clinical picture.One should first consider whether or not the rate of resolution is within the range of expected norms dependingon the patient’s underlying host factors, comorbidities, severity of illness and suspected pathogens. In stable or Printing: 4+2 colorslowly improving pneumonia, especially in the presence of comorbidities or host factors which are known to delay Paper: 170/90 GSM Indian Art Paperthe resolution of pneumonia, careful observation with or without therapy is warranted for 4-8 weeks.3When needed, further evaluation should include chest CT to look for sequestered areas of infection or for findings that suggest an alternative diagnosis. When pneumonia fails to resolve or when there is clinical progression, Frequency: Quarterlyfiberoptic bronchoscopy should be considered. Readership: 20,000Asian Journal of Critical Care Vol. 5, No. 4, October-December 2009 Price: ` 300/- Annual Subscription ` 1200/-
Asian Journal of Paediatric Practice From the desk oF group editor-in-chieF From preventive health care to treatment Smokers in the House, a Risk Factor for of childhood diseases to emergency care Hospitalization of Children with Flu and adolescence – all these subjects and Dr KK Aggarwal many more are covered in the much appreciated and read Asian Journal of Padma Shri and Dr BC Roy National Awardee Sr Physician and Cardiologist, Moolchand Medcity President, Heart Care Foundation of India Group Editor-in-Chief, IJCP Group Paediatric Practice. Editor-in-Chief, eMedinewS Chairman Ethical Committee, Delhi Medical Council Director, IMA AKN Sinha Institute (08-09) Hony. Finance Secretary, IMA (07-08) Chairman, IMA AMS (06-07) President, Delhi Medical Association (05-06) Under the able guidance of Dr Swati email@example.com A Bhave, Executive Editor, Association of large retrospective case-control study reported at the annual meeting of the Infectious Diseases Society of America (IDSA) says that having smokers in the house increases the possibility of a young child with flu needing inpatient care. Data from more than 1,300 laboratory-confirmed cases of children with influenza, collected by 10 sites in the CDC’s Emerging Infections Program in 2005-2008 were analyzed to identify risk factors for hospitalization Adolescent Child Care in India (AACCI), associated with laboratory-confirmed influenza. Analysis showed that if more than half of household members were smokers it doubled the chances a child would the journal serves as a practical guide for have a serious case of flu. According to Nila Dharan, MD, of the division of infectious diseases at the NYU School of Medicine in New York City, a family member who had been vaccinated against flu was protective, even if the the continuing education of Pediatricians child was not fully protected by immunizations. The study included 290 children ages six to 59 months (median age 20 months) with serious cases of flu; 1,089 age- and zip code-matched children with the flu who did not need inpatient care during the three influenza seasons acted as controls. The salient observations were as below. and Neonatologists. Age of the mother: if ≤26 years, the odds were doubled. The odds ratio (OR) was 2.1, with a 95% confidence interval (CI) from 1.3 to 3.4. The risk was increased if the child’s vaccinations were not up-to-date. The OR was 1.7, with a 95% CI from 1.1 to 2.7. If more than half of household members smoked, the child’s risk of needing inpatient care was doubled. The OR Specifications was 2.3, with a 95% CI from 1.0 to 5.3. The risk was similar to having any pulmonary condition, including asthma. If the child was not fully vaccinated for the flu, having any household member immunized was protective. The OR was 0.5, with a 95% CI from 0.3 to 0.8. Readership: 20,000 Underlying medical conditions also had an important role; presence of a hematologic or oncologic condition increased the risk by a factor of 12. According to Dr Dharan, other researchers have examined a possible association between exposure to smoking and Size: A4 a child’s risk of needing inpatient care for flu, but this is the largest study to date. n n n Pages: 36+4 Printing: 4+2 color Asian Journal of Paediatric Practice, Vol. 14, No. 1 Paper: 170/90 GSM Indian Art Paper Frequency: Quarterly Price: ` 300/- Annual Subscription ` 1200/-
Asian Journal of Ear, Nose Throat The management of diseases and the from the Desk of group eDitor-in-chiefNew Daily Persistent Headache latest techniques in the subspecialties of Otology, Rhinology and Laryngology need to be discussed and informed at length under a common platform efficiently provided by the Asian Journal of Ear, Dr KK Aggarwal Nose Throat. Padma Shri and Dr BC Roy Awardee It provides worldclass information to Sr Physician and Cardiologist Moolchand Medcity President, Heart Care Foundation of India Group Editor-in-Chief, IJCP Group Chief Editor, eMedinewS Member, Delhi Medical Council Director, IMA AKN Sinha Institute (08-09) Hony. Finance Secretary, IMA (07-08) Indian ENT practitioners under the guidance of its founder Editor, Dr VP Sood, Chairman, IMA AMS (06-07) President, Delhi Medical Association (05-06) firstname.lastname@example.org Secretary-cum-Managing Trustee, Dr SoodN Nasal Research Foundation, Past President ew daily persistent headache (NDPH) is a primary headache disorder in which headache begins one day and does not remit, in an individual without a headache history. The pathophysiology is poorly understood. Onset of NDPH can be triggered by certain events, such as infection.The incidence and prevalence of NDPH are unknown, but is rare. It is more frequent in children than in adults,and affects women more often than men. A characteristic feature is that the headache starts abruptly and is Association of Otorhinolaryngologists.daily and unremitting from, or almost from, the moment of onset, typically in individuals without a priorheadache history. SpecificationsThe diagnosis is clinical and requires ruling out secondary causes. Current diagnostic criteria exclude patientswith predominant migrainous features, many headache experts contend that the diagnosis of NDPH can bemade regardless of the presence of migrainous features. For patients with recent onset of suspected NDPH, oneshould do neuroimaging upon presentation. A lumbar puncture is indicated if clinical features suggest a possiblecentral nervous system infection or idiopathic intracranial hypertension. Readership: 20,000The differential diagnosis includes a number of secondary and primary causes of headache. It is particularlyimportant to consider cerebral venous sinus thrombosis, headache secondary to spontaneous cerebrospinal fluidleaks, idiopathic intracranial hypertension (pseudotumor cerebri), and giant cell arteritis. NDPH may take either of two subtypes: a self-limited one, or a persistent form which can last years or decadesand is challenging to treat. Size: A4For patients with primary NDPH, first classify the phenotype of NDPH as most similar to either migraine ortension-type headache, and then treating with appropriate preventive headache therapy accordingly. n n n Pages: 36+4Asian Journal of Ear, Nose Throat, April-June 2010 Printing: 4+2 color Paper: 170/90 GSM Indian Art Paper Frequency: Quarterly Price: ` 300/- Annual Subscription ` 1200/-
Indian Journal of Medilaw From thE dEsk oF group Editor-in-ChiEF There has been a considerable increase EditorialDriving Restrictions for Patients with Seizures in medicolegal cases in India in theKK Aggarwal past few years. This rise in medical law litigations is due to Consumer Protection Act (CPA) and awareness about protection of patients’ rights and consistent public Dr KK Aggarwal Padma Shri and Dr BC Roy National Awardee Sr Physician and Cardiologist, Moolchand Medcity demands for professional accountability. It is also a fact that, there are no apparent President, Heart Care Foundation of India Group Editor-in-Chief, IJCP Group Editor-in-Chief, eMedinewS Chairman Ethical Committee, Delhi Medical Council Director, IMA AKN Sinha Institute (08-09) Hony. Finance Secretary, IMA (07-08) and explicit guidelines in this regard. Chairman, IMA AMS (06-07) President, Delhi Medical Association (05-06) email@example.com http://twitter.com/DrKKAggarwal Krishan Kumar Aggarwal (Facebook) The Indian Journal of Medilaw was launched with the objective to keep the Indian Doctors updated about the current The seizure-free interval is the most practical and widely used measure of a patient’s driving risk. laws and implications on their practice. Longer seizure-free intervals (6-12 months) are associated with reduced risk of seizure-related motor vehicle accidents (MVA). Shortening seizure-free intervals to three months by some states has not been associated with increased MVAs. High seizure frequency, medical noncompliance, a history of MVAs and other factors increase the risk of seizure-related MVA. These should be considered to extend the seizure-free interval requirement for driving Specifications recommendations. An established pattern of purely nocturnal seizures, consistent and reliable seizure auras, clear provocation, Size: A4 or acute symptomatic seizures in a condition that is not associated with epilepsy or is unlikely to recur may reduce the seizure-free interval requirement. Pages: 36+4 Doctors should also consider other neurologic contraindications for driving in their patients with epilepsy, including impaired cognition and visual field defects. The Epilepsy Foundation is a good resource for the current state specific rules on driving and epilepsy. (www.epilepsyfoundation.org/living/wellness/transportation/driverlicensing.cfm) Doctors should discuss driving with patients and record this discussion in the medical record. This discussion Printing: 4+2 color should include the risk of driving.Indian Journal of Medilaw, September-November 2010 Paper: 170/90 GSM Indian Art Paper Quantity: 2-10,000. Frequency: Quarterly Price: ` 300/- Annual Subscription ` 1200/-
IJCP International Journals American Family Physician Indian Edition A peer-reviewed journal of the American Academy of Family Physicians November-December, 2006 Diagnosis and Diagnosing Rhinitis: Allergic vs. Nonallergic Treatment of Community- Assessment of Microscopic Hematuria in Acquired Tuberculosis Adults Diagnosis and Treatment of Chlamydia trachomatis Infection Diagnosis and Treatment of Neisseria gonorrhoeae Infections Diagnostic Approach to Pleural Effusion in Adults Hepatitis A Management of Hip Fracture: With Best Compliments from The Family Physician’s Role A Division of Pharmaceuticals Ltd.
Publishing Article in a Journal Publishing Articles in a Journal A scientific article, 4-6 pages long, can be published in any of our journals @ Rs 200,000/- per article inclusive of compilation, editing, layouting and Special Reprint 2009 printing subject to peer review/approval Methylcobalamin, Pyridoxine and Nicotinamide in by the Editorial Board. Diabetic Neuropathy: A Review S Jayaram*, Akash Khobragade**, Deepak Langade† ABstRAct Diabetes is the most common etiological factor for peripheral neuropathy (PN). While conventional theory says that prolonged hyperglycemia results in the complications associated with diabetes, including neuropathy, a recent study found that PN can manifest even in individuals with abnormal Journal Article Reprints glucose tolerance, a prediabetic condition. A combination of methylcobalamin, pyridoxine and nicotinamide thus has additive and synergistic effects on the damaged nerve in diabetic neuropathy which protect the nerve from further damage, restore its structural and functional integrity and cause a recovery of function. Key words: Hyperglycemia, prediabetic, polyneuropathy, adenosylcobalamin, vitamin B6, nicotinic acid, Specifications myelin sheath, axon Background incidence approaches 50% for patients with diabetes Peripheral neuropathy (PN) is characterized by pain, for more than 25 years.1 A study conducted in South numbness and tingling in the extremities and slow India to find the prevalence and risk factors, found nerve conduction. It affects a significant percentage a PN prevalence of 19.1% among type 2 diabetics of the Indian population and can be extremely debilitating. Around 7% of patients usually have attending the diabetic clinic. Neuropathy was diagnosed if the vibratory threshold of the great toe exceeded 25. The incidence of PN increases with Size: A4 neuropathy upon diagnosis of diabetes, and the increase in age and duration of diabetes.2 Based on a *Hon. Professor of Medicine compilation of studies from different parts of the world, the World Health Organization (WHO) has projected Paper: 110 GSM Indian Art Paper Bombay Hospital, Mumbai that the maximum increase in diabetes would occur in **Resident India.3 Considering the large population and the high † Clinical Pharmacology, Ex-lecturer Dept. of Pharmacology Grant Medical College and Sir JJ Group of Hospitals prevalence of diabetes, the burden of diabetes and it’s complications in India would become enormous. Printing: 4 + 2 color offset printing Mumbai Pathophysiology of diabetic neuropathy Pages: 4/6/8 pages Address for correspondence Dr Deepak Langade Diabetes is the most common etiological factor for PN 503/E-7, Runwal Estate, Opp. Lawkim and it is also the most studied in terms of pathogenesis. Ghodbunder Road, Thane (W), Mumbai - 400 607 While conventional theory says that prolonged E-mail: firstname.lastname@example.org hyperglycemia results in the complications associated June 2009 INDIAN JOURNAL OF CLINICAL PRACTICE l VOL. 20, NO. 1 One full page Advertisement
Advertisement Tariff (Code A 20)Position Dimension AmountCover Double Spread 24.5 × 39.5 ` 200,000Gate Fold False Cover 24.5 X 17.5 ` 150,000Front page strip 19.5 X 5.0 ` 150,000Inside Front Cover 24.5 X 17.5 ` 100,000Front Solus Quarter 14.5 X 11.0 ` 100,000Back Cover 24.5 X 17.5 ` 1, 50,000Inside Back Cover 24.5 X 17.5 ` 100,000Full Page 4 Color 24.5 X 17.5 ` 40,000Half page 4 Color 12.25 X 17.5 ` 25,000Full Page 2 Color 24.5 X 17.5 ` 30,000Half Page 2 Color 12.5 X 17.5 ` 20,000B/W Full Page 24.5 X 17.5 ` 15,000B/W Half Page 12.25 X 17.5 ` 12,000Utility Corner 4 Color Quarter 7.0 X 5.0 ` 50,000
Handbooks ECG F ormulaE IJCP’s Handbooks are a highly coveted academic gifts for doctors. Covering Indications of ECG The main indications are for the evaluation of various topics of relevance to clinicians,1. The electric axis of the heart these Handbooks give a complete insight2. Heart rate monitoring3. Arrhythmias on the subject discussed therein. a. Supra ventricular arrhythmias b. Ventricular arrhythmias An ideal companion to doctors, Handbooks c. Disorders in the activation sequence- AV conduction defects have a long shelf life. d. Bundle-branch block e. Wolff-Parkinson-White syndrome4. Increase in wall thickness or size of the atria and ventricles a) Atrial enlargement (hypertrophy) b) Ventricular enlargement (hypertrophy)5. Myocardial ischemia and infarction a. Ischemia b . Infarction6. Drug effect a Digitalis b. Quinidine Specifications7. Electrolyte imbalance a. Potassium b. Calcium Size: 7 x 4.5 inches8. Carditis a. Pericarditis Pages: 32-56 +4 pages b. Myocarditis9. Pacemaker monitoring Paper: 210/90 GSM Indian Art Paper Printing: 4+2 color offset printing Binding: Centre stitch/ perfect binding